Exhibit 99.2

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value, of Titan Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

 

Dated: April 25, 2022

 

  ACTIVIST INVESTING LLC
   
  By:

/s/ David E. Lazar

    Name: David E. Lazar
    Title: Chief Executive Officer

 

  /s/ David E. Lazar
  DAVID E. LAZAR